Table 7.
Effect of Bacillus subtilis fermentation extract delivery route on differentially abundant bacterial taxa between treatment groups.
| Taxa (log-transformed counts) | Treatments1 |
P value2 | False discovery rate (FDR) | |||||
|---|---|---|---|---|---|---|---|---|
| Control | In-feed antibiotics | In -water probiotics | In-feed probiotics | In ovo saline | In ovo probiotics | |||
| Phylum | Actinobacteria | 0.002 | 0.013 | |||||
| Class | Coriobacteriia | 0.001 | 0.014 | |||||
| Order | Coriobacteriales | 0.002 | 0.009 | |||||
| Rhizobiales | 0.002 | 0.009 | ||||||
| Family | Streptococcaceae | 0.000 | 0.000 | |||||
| Eggerthellaceae | 0.002 | 0.002 | ||||||
| Xanthobacteraceae | 0.007 | 0.045 | ||||||
| Genus | Streptococcus | 0.000 | 0.000 | |||||
| DNF0089 | 0.000 | 0.000 | ||||||
1
Treatment groups include control (CTRL), in-feed antibiotic treatment containing CTRL + 0.05% bacitracin methylene disalicylate (BMD), CTRL diet + in-water probiotics (containing 0.025 g/L of Bacillus subtilis fermentation extract), in-feed probiotics containing CTRL + 0.005% Bacillus subtilis, in ovo saline group injected with 200 μL of physiological saline (0.9% NaCl), and in ovo probiotics group injected with 200 μL of Bacillus subtilis fermentation extract (10 × 106 cfu) in n = 12 observations per treatment.
2
Significance was set at P ≤ 0.05.